YY2 Serves as a Novel Prognostic Biomarker Correlated with Immune Microenvironment and Glycolysis in Esophageal Carcinoma
YY2 may serve as a promising prognostic biomarker and an innovative therapeutic target for patients with ESCA, regulating cell proliferation, migration, immune microenvironment, and glycolysis.
Authors
- Haimei Gou
- Xiaowu Zhong (ORCID: https://orcid.org/0000-0001-5143-5838)
- Xin Chen (ORCID: https://orcid.org/0000-0003-3668-4830)
- Shuang He (ORCID: https://orcid.org/0009-0008-6960-9806)
- Cheng Jiao (ORCID: https://orcid.org/0000-0002-4191-4656)
- Can Luo
- Hui Yang (ORCID: https://orcid.org/0000-0003-3590-722X)
Institutions
- North Sichuan Medical University (CN)
- Affiliated Hospital of North Sichuan Medical College (CN)
Publication Details
- Journal
- Current Genomics
- Published
- 2025-02-07
- DOI
- https://doi.org/10.2174/0113892029358348250124064940
- Citations
- 5
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 10.03